ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38 | +100.0% | 23,552 | +683.5% | 0.00% | – |
| Q4 2022 | $19 | -99.9% | 3,006 | +81.1% | 0.00% | – |
| Q3 2021 | $20,000 | -42.9% | 1,660 | 0.0% | 0.00% | – |
| Q2 2021 | $35,000 | -23.9% | 1,660 | 0.0% | 0.00% | – |
| Q1 2021 | $46,000 | +7.0% | 1,660 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | -30.6% | 1,660 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -27.1% | 1,660 | 0.0% | 0.00% | – |
| Q2 2020 | $85,000 | +60.4% | 1,660 | 0.0% | 0.00% | – |
| Q1 2020 | $53,000 | -45.9% | 1,660 | 0.0% | 0.00% | – |
| Q4 2019 | $98,000 | +60.7% | 1,660 | 0.0% | 0.00% | – |
| Q3 2019 | $61,000 | -57.9% | 1,660 | -46.9% | 0.00% | – |
| Q2 2019 | $145,000 | +16.0% | 3,128 | 0.0% | 0.00% | – |
| Q1 2019 | $125,000 | -10.1% | 3,128 | 0.0% | 0.00% | – |
| Q4 2018 | $139,000 | 0.0% | 3,128 | 0.0% | 0.00% | – |
| Q3 2018 | $139,000 | +13.0% | 3,128 | 0.0% | 0.00% | – |
| Q2 2018 | $123,000 | -45.8% | 3,128 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $227,000 | +10.2% | 3,128 | 0.0% | 0.00% | – |
| Q4 2017 | $206,000 | +216.9% | 3,128 | +140.6% | 0.00% | – |
| Q3 2017 | $65,000 | +8.3% | 1,300 | 0.0% | 0.00% | – |
| Q2 2017 | $60,000 | +30.4% | 1,300 | 0.0% | 0.00% | – |
| Q1 2017 | $46,000 | +187.5% | 1,300 | 0.0% | 0.00% | – |
| Q4 2016 | $16,000 | -55.6% | 1,300 | -50.0% | 0.00% | – |
| Q3 2016 | $36,000 | +176.9% | 2,600 | +100.0% | 0.00% | – |
| Q2 2016 | $13,000 | -40.9% | 1,300 | 0.0% | 0.00% | – |
| Q1 2016 | $22,000 | -24.1% | 1,300 | 0.0% | 0.00% | – |
| Q4 2015 | $29,000 | -6.5% | 1,300 | 0.0% | 0.00% | – |
| Q3 2015 | $31,000 | -70.8% | 1,300 | 0.0% | 0.00% | – |
| Q2 2015 | $106,000 | -11.7% | 1,300 | 0.0% | 0.00% | – |
| Q1 2015 | $120,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |